Green Light photoselective vaporization of the prostate: a safe and effective treatment for elderly high-risk benign prostate hyperplasia patients with gland over 80 ml

• Published in: Lasers in medical science 2018-11, Vol.33 (8), p.1693-1698
• Main Authors: Sun, Jie, Shi, An, Tong, Zhen, Chi, Chenfei
• Format: Article
• Language: English
• Subjects: Aging; Benign; Blood transfusion; Catheterization; Complications; Dentistry; Diabetes mellitus; Flow velocity; Genital diseases; Geriatrics; Glands; Hyperplasia; Hypertension; Inflammation; Inflammatory response; Intubation; Lasers; Medicine; Medicine & Public Health; Older people; Optical Devices; Optics; Original Article; Patients; Photonics; Prostate; Quality of life; Quantum Optics; Risk; Risk groups; Transfusion; Ultrasound; Urine; Vaporization
• ISSN: 0268-8921; 1435-604X
• DOI: 10.1007/s10103-018-2521-x

To analyze the efficacy of Green Light photoselective vaporization of the prostate (PVP) in elderly high-risk benign prostatic hyperplasia (BPH) patients with glands over 80 ml. From December 2013 to February 2016, we allocated 84 elderly (age 71–97) high-risk patients who underwent preoperative transrectal ultrasound (TRUS) examination with glands over 80 ml and divided them into two groups to receive 120 W ( n  = 40) and 180 W ( n  = 44) PVP. All the patients have been observed at least one intraoperative comorbidity: hypertension, diabetes mellitus, NYHA II, or combined. They were followed up for 12 months. All the conventional parameters were compared in this study. All the patients received successful operations without severe complications, and no patient needed blood transfusion. The operation time and catheterization time of the 180 W patients were significantly shorter than that of the 120 W patients ( p